课题基金 / 基金详情

Heterogeneous cell wall homeostasis as a survival strategy in stationary phase: balancing cell growth, antibiotic production, and envelope stress response in Bacillus subtilis

Heterogeneous cell wall homeostasis as a survival strategy in stationary phase: balancing cell growth, antibiotic production, and envelope stress response in Bacillus subtilis
异质细胞壁稳态作为稳定期的生存策略:平衡枯草芽孢杆菌的细胞生长、抗生素产生和包膜应激反应
批准号:
217882361
负责人:
Dr. Georg Fritz
金额:
$0.0万
依托单位国家:
德国
项目类别:
Priority Programmes
财政年份:
2012
资助国家:
德国
项目状态:
已结题
起止时间:
2011-12-31 至 2018-12-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The cell envelope is an essential yet highly dynamic structure that protects the bacterial cell from its environment. Maintaining its integrity throughout the growth cycle - even in the face of antibiotic threat - is absolutely essential for survival. While significant progress has been made in recent years on understanding envelope homeostasis during balanced growth, little is known on the regulatory and physiological adjustments in stationary phase. When faced with unfavorable growth conditions, the Gram-positive model organism Bacillus subtilis embarks on a complex differentiation program, which results in the formation of different subpopulations that e.g. become competent, form biofilms or differentiate into dormant endospores. This diversification is attributed to bet-hedging strategies that aim at maximizing the survival of the population by 'being prepared' for a number of different fates. But so far little is known about the physiological relevance and correlation of other stationary phase survival strategies, including the production of antimicrobial peptides (AMPs) that target cell wall biosynthesis, the resulting cell envelope stress responses (CESR), and the cell growth in the remaining vegetative cells. These will be the focus of this proposal, which rests on the following cornerstones: (i) The growth rate of individual cells is broadly heterogeneous resulting in widely mixed populations of vegetative, differentiating and lysing cells. (ii) AMP production is also a heterogeneous and transient strategy. (iii) Since AMPs target cell wall biosynthesis, their inhibitory action is coupled to actively growing cells and should therefore also be heterogeneous. This is expressed in (iv) the bimodal induction observed for the damage-sensing Lia system, which responds to perturbations of the Lipid II cycle of cell wall biosynthesis. Based on this, we propose that the Lia response in stationary phase represents a 'physiological triple AND-gate' that requires AMP production, cell growth, and insufficient intrinsic protection. To address this hypothesis and ultimately explain the correlation between the heterogeneity in AMP production, stationary phase growth and induction of CESR, we pursue four major goals. (i) We aim at extracting a quantitative, single-cell based picture of the correlation and epigenetic inheritance between cell growth, AMP production, and CESR. (ii) We want to develop a quantitative and dynamic mathematical model of the Lipid II cycle, in order to simulate the correlation between AMP production and the resulting induction of the CESR. (iii) In combining the above two goals, we aim at Identifying the stochastic/regulatory processes responsible for determining the cell fate decision regarding sporulation, AMP production and induction of the CESR. (iv) Ultimately, we would like to unravel the physiological relevance of phenotypic heterogeneity in cell envelope homeostasis and Lia-mediated CESR for stationary phase survival.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
全细胞疫苗Cell@MnO2的乳腺癌术后免疫响应监测与放射免疫治疗研究
  • 批准号:
    QN25H220002
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    顾媛
  • 依托单位:
染色体外环状DNA以cell-in-cell途径促进基因横向传递和扩增的研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    15.0万元
  • 批准年份:
    2024
  • 负责人:
    王锐智
  • 依托单位:
GMFG/F-actin/cell adhesion 轴驱动 EHT 在造 血干细胞生成中的作用及机制研究
  • 批准号:
    TGY24H080011
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    李鸿鹄
  • 依托单位:
糖尿病ED中成纤维细胞衰老调控内皮细胞线粒体稳态失衡的机制研究
  • 批准号:
    82371634
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    赵福军
  • 依托单位: